Thermo Electron, Fisher Scientific, Invitrogen, Stratagene, Enzo, Sigma-Aldrich, Genetix, PerkinElmer, Beckman Coulter, Combimatrix, Protedyne, Roche | GenomeWeb
Thermo Electron Q2 Revenues Rise, But Profits
Fall 20 Percent; Acquires Mass Spec Firm
 
Thermo Electron this week reported that its total second-quarter revenue increased 9 percent, but its profits tumbled 20 percent.
 
Total receipts for the three months ended July 1 increased to $713 million from $654 million during the same period one year ago.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.